Skip to content

Ayurvedic Management of Dyslipidemia Through Virechan Karma And Shaman Snehpana

A Clinico Comparative Study Of Shamana Snehpana With Triphaladi Taila and Virechana Karma In The Management Of Dyslipidemia

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084599
Enrollment
30
Registered
2025-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Government Akhand Anand Ayurved College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age between 18 to 6O years 2 Patients having Total Cholestrol more than 2OOmgdl OR LDL more than 1OO mgdl OR Triglycerides more than 15O mgdl OR HDL less than 4O mgdl OR Apolipoprotein B more than 12O mgdl 3 Snehpana yogya 4 Virechan yogya

Exclusion criteria

Exclusion criteria: 1 Age below 18 and more than 6O years 2 Patients with uncontrolled HTN and DM 3 Pregnant and lactating women 4 Virechan Ayogya 5 Snehpana Agyogya 6 Known case of heart disease Stroke liver disease COPD 7 Acute or chronic infectious diseases like TB STDs AIDS 8 On medications like corticosteroids, hormonal therapy antidepressants

Design outcomes

Primary

MeasureTime frame
Outcome will be based on LIPID PROFILE OR Apolipoprotein B before and after treatment that is will be based on objective criterion Patients having Total Cholestrol more than 2OOmgdl OR LDL more than 1OO mgdl OR Triglycerides more than 15O mgdl OR HDL less than 4O mgdl OR Apolipoprotein B more than 12O mgdl Total Cholestrol LDL Triglycerides HDL Apolipoprotein BTimepoint: 1 month

Secondary

MeasureTime frame
Patients will be assessed by blood investigations cbc, urine routine and microscopic.Timepoint: 1 month

Countries

India

Contacts

Public ContactDrKrupali Raut

Government Akhandanand Ayurved College

rautkajal77@gmail.com8849830133

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026